Development
Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -97.49% | -69.80% | -81.24% | -8.11% | 11.27% |
| Total Depreciation and Amortization | -1.50% | -0.70% | 3.83% | 9.75% | 21.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 211.40% | 262.78% | 672.95% | 26.63% | 100.96% |
| Change in Net Operating Assets | 20.74% | -8.71% | -59.96% | -48.44% | 27.53% |
| Cash from Operations | -31.89% | -12.72% | -20.20% | -8.98% | 35.34% |
| Capital Expenditure | 11.96% | 9.53% | 5.48% | -1.40% | 1.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -9,843.80% | -5.68% | -7.90% | 88.78% | 99.06% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 501.77% | -70.05% | -128.28% | -207.49% | -156.38% |
| Cash from Investing | -183.93% | -4.08% | -7.50% | 63.83% | 70.04% |
| Total Debt Issued | -- | -25.16% | -0.67% | -- | -- |
| Total Debt Repaid | 22.03% | 48.73% | -13.77% | 84.35% | 64.30% |
| Issuance of Common Stock | -67.45% | 51.78% | 48.85% | 96.10% | 90.10% |
| Repurchase of Common Stock | -- | -5,194.44% | 18.97% | 82.26% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.18% | -6.34% | -6.29% | -6.11% | -6.08% |
| Other Financing Activities | -36.67% | -91.71% | -16.39% | -102.66% | -102.92% |
| Cash from Financing | 47.25% | -74.68% | -32.23% | -603.86% | -451.68% |
| Foreign Exchange rate Adjustments | 105.61% | 124.05% | 89.12% | -194.51% | -208.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -227.31% | -311.68% | -459.84% | -32.80% | 32,800.00% |